264 related articles for article (PubMed ID: 6303677)
1. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Spinella G; Majorana M
Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
[No Abstract] [Full Text] [Related]
2. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
Raspanti D; Cameli AM; Trapani M; Dorigo D; Mazzotta A; Negro P
Clin Ter; 1987 Jun; 121(6):479-83. PubMed ID: 2973884
[No Abstract] [Full Text] [Related]
3. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
Musil HE
Med Welt; 1973 Jan; 24(3):103-13. PubMed ID: 4617835
[No Abstract] [Full Text] [Related]
4. [A new preparation for peripheral arterial occlusive diseases].
Knüchel F
Med Welt; 1982 Jan; 33(1):90. PubMed ID: 6276645
[No Abstract] [Full Text] [Related]
5. [Clinical and instrumental evaluation of patients with chronic peripheral arterial occlusive disease after prolonged administration of suloctidil].
Gregoratti L; Redaelli G; Limido P; Ghiringhelli L
Clin Ter; 1982 Sep; 102(6):607-19. PubMed ID: 6291844
[No Abstract] [Full Text] [Related]
6. Controlled trial of suloctidil in intermittent claudication.
Verhaeghe R; Van Hoof A; Beyens G
J Cardiovasc Pharmacol; 1981; 3(2):279-86. PubMed ID: 6166799
[TBL] [Abstract][Full Text] [Related]
7. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
Marongiu G; Dettori G; Gadeddu A; Noya G; Angius P; Biglioli P
Minerva Cardioangiol; 1983; 31(7-8):407-10. PubMed ID: 6316206
[No Abstract] [Full Text] [Related]
8. [Transcutaneous oxygen pressure during intra-arterial infusions].
Creutzig A; Dau D; Alexander K
Vasa; 1984; 13(3):207-12. PubMed ID: 6485524
[No Abstract] [Full Text] [Related]
9. Intermittent claudication: Suloctidil v.s. placebo treatment.
Holm J; Lindblad L; Scherstén T; Suurkula M
Vasa; 1984; 13(2):175-8. PubMed ID: 6331019
[No Abstract] [Full Text] [Related]
10. [Determinations of clinical variations and lipid metabolism in patients with chronic ischemia of the lower extremities by means of a pentosan sulfonic ester and xanthinol niacinate combination].
González González M; Azcona Elizalde JM; Lorente Navarro MC; Duato Jane A
Angiologia; 1979; 31(4):180-4. PubMed ID: 382919
[No Abstract] [Full Text] [Related]
11. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
Caimi G; Catania A; Frazzetta F; Capobianco D; Francavilla G; Romano A; Sarno A
Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
[TBL] [Abstract][Full Text] [Related]
12. A double-blind study comparing suloctidil and placebo in chronic peripheral arteriopathy.
Gillot P
Curr Ther Res Clin Exp; 1976 Nov; 20(5):637-44. PubMed ID: 825349
[No Abstract] [Full Text] [Related]
13. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
Benignetti G; Fabbri F; Benvenuti C
Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
[No Abstract] [Full Text] [Related]
14. [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
Gómez Reyes D; Rojas Hidalgo E
Rev Clin Esp; 1988 Jan; 182(1):3-6. PubMed ID: 3375512
[No Abstract] [Full Text] [Related]
15. The use of Xavin infusions in obliterating peripheral arterial disorders.
Keller L; Landi A; Bársony J
Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
[No Abstract] [Full Text] [Related]
16. [Effect of a 3-month-interval running exercise in combination with vasodilative therapy on microcirculation of the lower leg in peripheral arterial circulation disorders (stage I and II)].
Siewert H; Winterfeld HJ; Strangfeld D; Schmidt HH; Correns HJ
Z Alternsforsch; 1983; 38(5):377-81. PubMed ID: 6659566
[TBL] [Abstract][Full Text] [Related]
17. [Use of xavin in vascular diseases of the lower extremities].
Volgin EG
Klin Med (Mosk); 1980 Oct; 58(10):46-50. PubMed ID: 7442096
[No Abstract] [Full Text] [Related]
18. Combination of suloctidil and anticoagulation in the prevention of reocclusion after femoro-popliteal PTA.
Mahler F; Schneider E; Gallino A; Bollinger A
Vasa; 1987; 16(4):381-5. PubMed ID: 2827398
[No Abstract] [Full Text] [Related]
19. A double-blind trial of suloctidil v. placebo in intermittent claudication.
Jones NA; De Haas H; Zahavi J; Kakkar VV
Br J Surg; 1982 Jan; 69(1):38-40. PubMed ID: 6274471
[TBL] [Abstract][Full Text] [Related]
20. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
Davì G; Pinto A; Novo S; Avellone G; Galati D; Mazzola A
Clin Ter; 1982 Oct; 103(2):131-7. PubMed ID: 6295693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
